Multiple myeloma is a common hematological malignancy that has its origins in plasma cells. Despite treatment becoming more sophisticated, there is still currently no cure. However, immunotherapy targeting CD38/CD3 is proving to be very promising.
CAR-T Therapy: Combating Cytokine Release Syndrome
Sponsored Content by ACROBiosystemsMay 21 2021
CAR-T cell therapy offers the hope of a cure to a number of cancer patients. Yet, in spite of the great effectiveness, more attention has been paid to the toxicity of the therapy known as cytokine release syndrome (CRS).
This article is aimed at summarizing the main points of assessment, grading and management of CRS in CAR-T Therapy and provide answers to the following questions:
How to identify the onset of CRS clinically?
What is CRS management?
How to use tocilizumab in CRS management？
Assessment, grading and management of CRS in CAR-T therapy
CAR-T Therapy: Syndrome Released by Cytokine news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.